Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Toniatti

Showing results (31-40 of 39) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 39 results.
The EMBO Journal|May 1, 1995
Two distinct and independent sites on IL-6 trigger gp 130 dimer formation and signallingG Paonessa, R Graziani, A De Serio, et al.
The EMBO Journal|March 15, 1994
Generation of interleukin-6 receptor antagonists by molecular-modeling guided mutagenesis of residues important for gp130 activationR Savino, A Lahm, A L Salvati, et al.
The EMBO Journal|June 3, 1996
Engineering human interleukin-6 to obtain variants with strongly enhanced bioactivityC Toniatti, A Cabibbo, E Sporena, et al.
Annals of the New York Academy of Sciences|July 21, 1995
The molecular design of human IL-6 receptor antagonistsA Lahm, R Savino, A L Salvati, et al.
Blood|June 1, 1996
Human interleukin-6 receptor super-antagonists with high potency and wide spectrum on multiple myeloma cellsE Sporeno, R Savino, L Ciapponi, et al.
Gene Therapy|October 16, 2002
Tight control of gene expression by a helper-dependent adenovirus vector carrying the rtTA2(s)-M2 tetracycline transactivator and repressor systemV Salucci, A Scarito, L Aurisicchio, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 17, 1999
Site-specific integration mediated by a hybrid adenovirus/adeno-associated virus vectorA Recchia, R J Parks, S Lamartina, et al.
Immunity|March 1, 1997
Role of IL-6 and its soluble receptor in induction of chemokines and leukocyte recruitmentM Romano, M Sironi, C Toniatti, et al.
Gene Therapy|March 11, 2011
Intratumor RNA interference of cell cycle genes slows down tumor progressionS Dharmapuri, D Peruzzi, E Marra, et al.
Pageof 4

Showing results (31-40 of 39) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 39 results.
The EMBO Journal|May 1, 1995
Two distinct and independent sites on IL-6 trigger gp 130 dimer formation and signallingG Paonessa, R Graziani, A De Serio, et al.
The EMBO Journal|March 15, 1994
Generation of interleukin-6 receptor antagonists by molecular-modeling guided mutagenesis of residues important for gp130 activationR Savino, A Lahm, A L Salvati, et al.
The EMBO Journal|June 3, 1996
Engineering human interleukin-6 to obtain variants with strongly enhanced bioactivityC Toniatti, A Cabibbo, E Sporena, et al.
Annals of the New York Academy of Sciences|July 21, 1995
The molecular design of human IL-6 receptor antagonistsA Lahm, R Savino, A L Salvati, et al.
Blood|June 1, 1996
Human interleukin-6 receptor super-antagonists with high potency and wide spectrum on multiple myeloma cellsE Sporeno, R Savino, L Ciapponi, et al.
Gene Therapy|October 16, 2002
Tight control of gene expression by a helper-dependent adenovirus vector carrying the rtTA2(s)-M2 tetracycline transactivator and repressor systemV Salucci, A Scarito, L Aurisicchio, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 17, 1999
Site-specific integration mediated by a hybrid adenovirus/adeno-associated virus vectorA Recchia, R J Parks, S Lamartina, et al.
Immunity|March 1, 1997
Role of IL-6 and its soluble receptor in induction of chemokines and leukocyte recruitmentM Romano, M Sironi, C Toniatti, et al.
Gene Therapy|March 11, 2011
Intratumor RNA interference of cell cycle genes slows down tumor progressionS Dharmapuri, D Peruzzi, E Marra, et al.
Pageof 4